VFG
HELP

Victory Financial Group’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Victory Financial Group’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.17K Buy
+308
New +$4.03K ﹤0.01% 78

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Victory Financial Group's HELP Position: Q2 2024 in Review

Victory Financial Group opened a new position in Helus Pharma Inc. Common Stock (HELP) in Q2 2024: 308 shares worth $3.17K. The stake represents ﹤0.01% of the portfolio and ranks #78 among its holdings.

98 funds tracked by Wall St. Rank hold HELP as of Q2 2024.

  • Victory Financial Group held 308 shares of Helus Pharma Inc. Common Stock worth $3.17K as of Q2 2024.
  • Helus Pharma Inc. Common Stock was a new Victory Financial Group position in Q2 2024.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Victory Financial Group's portfolio in Q2 2024, its #78 holding.
  • 98 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2024.

Based on Victory Financial Group's 13F filing for Q2 2024, filed 14 Aug 2024.